HYN-17968-98497
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 283 / NC
- Registered
- 2022-07-21
- Relationship
- Child or adolescent in my care
- Guardian
- RM5-10829-35346
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-21
Registered in v-safe
-
2022-07-21
Dose 1 — Pfizer-BioNTech
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-28
- 2022-08-06
- 2022-08-11
-
2022-08-17
Dose 2 — Pfizer-BioNTech
- 2022-08-17
- 2022-08-18
- 2022-08-19
- 2022-08-20
- 2022-08-21
- 2022-08-22
- 2022-08-23
- 2022-08-24
- 2022-08-31
- 2022-09-07
-
2022-09-16
Survey response — 28 day, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
- 2022-09-21
- 2022-09-28
- 2022-11-18
- 2023-02-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-21 | Pfizer-BioNTech | No |
| 2 | 2022-08-17 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3)
Symptoms: Cough and runny nose
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release